CPR Invest - Reactive - I EUR - Acc ISIN : LU1103787930
CPR Invest - Reactive - I EUR - Acc
I(C) - LU1103787930
Asset class: Balanced
YTD
As of 18/11/20260.69%
Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.
NAV
As of 19/11/2026€147,473.92
SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8
Fund AUM
As of 19/11/2026€58.54M
This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.
NAVs
NAV from 22/11/2016 to 19/11/2026
Select period
Performance
Change in NAV in base 100
FundCPR Invest - Reactive - I EUR - Acc (33.75% over the period)
Select period
B. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
Change in NAV in base 100Rolling performancesYear-on-year return (365 days)Annual returnsRisk indicatorsPerformances Scenarios
FundCPR Invest - Reactive - I EUR - Acc (33.75% over the period)
Select period
B. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
Portfolio Analysis
Repartition 10/31/2026
Main Lines in Portfolio (Source: Amundi)Geographical breakdown (Source: Amundi)CurrencyPortfolio Breakdown by Maturity (Source: Amundi)
Sector | Weight | |
|---|---|---|
| AM EURO LIQUIDITY S-T RESP - Z (C) | Money Market Investments | 9.75% |
| CPR INVEST - CLIMATE BONDS EURO - Z EUR | Investment Grade EMU | 6.55% |
| AMUNDI EURO LIQUIDITY SELECT - Z (C) | Money Market Investments | 6.18% |
| AM MSCI WRLD SCREENED UCITS ETF (PAR) | Equities World | 5.46% |
| abrdn Em Mkt Lcl Ccy Dbt K Acc EUR | Govies Emerging Global | 5.41% |
| CPR ABSOLUTE RETURN BONDS - Z (C) | Absolute Return Fixed Income | 5.35% |
| Amundi USD Corporate Bond ESG ETF DR C | Investment Grade USA | 5.18% |
| CPR INVEST - CREDIXX GLOB HI YIELD | High Yield World | 4.72% |
| ARI - EUROPEAN CREDIT- I2 - C | Investment Grade EMU | 4.24% |
| BFT CREDIT OPPORT ISR CLIMAT - I2 (C) | Investment Grade Europe | 3.84% |
Management commentary
Effective date: 31/10/2026The month of October was marked by a new surge in energy prices, against a backdrop of persistent geopolitical tensions in the Middle East. Brent crude rose by nearly 14%, while natural gas returned to its highest levels since the end of 2022. This dynamic led to an acceleration in headline inflation in both the eurozone and the United States, without, at this stage, causing a comparable increase in core components. Economic activity remained generally resilient, particularly in the United States, even though the deterioration of the US labor market and the slowdown in European business surveys sent more mixed signals.
In this context, the Fed, the ECB, and the Bank of Japan kept their key interest rates unchanged, while maintaining cautious communication in the face of inflationary risks. Bond markets benefited from this monetary pause and a flight to safe-haven assets, resulting in a significant decline in sovereign yields. Conversely, equity markets were shaken at the end of the month by disappointing earnings reports from several major technology companies, which reignited questions about the profitability of massive investments in artificial intelligence. Technology stocks, semiconductors, and emerging markets thus underperformed, while European equities and sectors less exposed to the AI theme proved more resilient.
In light of this environment, we maintain a slightly cautious bias on equities. The most concentrated exposures to large US technology stocks, the Nasdaq, and semiconductors have been reduced, as well as certain thematic and emerging market positions. These adjustments aim to limit the sensitivity of allocations to segments with the highest valuation levels and earnings expectations. At the same time, we are favoring broader indices to improve diversification and reduce concentration risk.
From a sector perspective, we are strengthening our preference for healthcare and energy. Healthcare offers more defensive characteristics, better earnings visibility, and relatively limited sensitivity to the economic cycle. Energy, for its part, benefits from rising hydrocarbon prices and serves as a partial hedge against persistent geopolitical and inflationary tensions. Exposure to emerging markets remains more measured, given their sensitivity to the technology sector, the ongoing weakness of Chinese domestic demand, and a still restrictive rate environment.
In bond markets, we favor a contained duration, mainly in the five- to seven-year maturities. This positioning allows us to benefit from carry and a potential further easing of yields, while limiting exposure to longer maturities, which are more vulnerable to a renewed rise in inflation expectations. Government bonds also continue to play an important role in diversification and protection in the event of renewed risk aversion in equity markets.
Within credit, the euro investment grade segment remains favored due to the quality of issuers and an always attractive risk-return profile. US high yield also offers an interesting source of carry, but only within a rigorous selection framework, given the level of financing rates and the risks of dispersion among issuers. Finally, emerging market debt in local currencies can provide additional diversification, provided a selective approach is maintained regarding currency, inflation, and monetary policy risks specific to each country.
In this context, the Fed, the ECB, and the Bank of Japan kept their key interest rates unchanged, while maintaining cautious communication in the face of inflationary risks. Bond markets benefited from this monetary pause and a flight to safe-haven assets, resulting in a significant decline in sovereign yields. Conversely, equity markets were shaken at the end of the month by disappointing earnings reports from several major technology companies, which reignited questions about the profitability of massive investments in artificial intelligence. Technology stocks, semiconductors, and emerging markets thus underperformed, while European equities and sectors less exposed to the AI theme proved more resilient.
In light of this environment, we maintain a slightly cautious bias on equities. The most concentrated exposures to large US technology stocks, the Nasdaq, and semiconductors have been reduced, as well as certain thematic and emerging market positions. These adjustments aim to limit the sensitivity of allocations to segments with the highest valuation levels and earnings expectations. At the same time, we are favoring broader indices to improve diversification and reduce concentration risk.
From a sector perspective, we are strengthening our preference for healthcare and energy. Healthcare offers more defensive characteristics, better earnings visibility, and relatively limited sensitivity to the economic cycle. Energy, for its part, benefits from rising hydrocarbon prices and serves as a partial hedge against persistent geopolitical and inflationary tensions. Exposure to emerging markets remains more measured, given their sensitivity to the technology sector, the ongoing weakness of Chinese domestic demand, and a still restrictive rate environment.
In bond markets, we favor a contained duration, mainly in the five- to seven-year maturities. This positioning allows us to benefit from carry and a potential further easing of yields, while limiting exposure to longer maturities, which are more vulnerable to a renewed rise in inflation expectations. Government bonds also continue to play an important role in diversification and protection in the event of renewed risk aversion in equity markets.
Within credit, the euro investment grade segment remains favored due to the quality of issuers and an always attractive risk-return profile. US high yield also offers an interesting source of carry, but only within a rigorous selection framework, given the level of financing rates and the risks of dispersion among issuers. Finally, emerging market debt in local currencies can provide additional diversification, provided a selective approach is maintained regarding currency, inflation, and monetary policy risks specific to each country.
Characteristics
General data
Inception date
29/08/2014First Nav Date
11/04/2011Currency
EURShow more
Valuation
DailyMinimum initial investment
100000 eurosMinimum additional investment
1 10/1000° share(s)/equityCosts Composition
| One-off costs upon entry or exit (Investment EUR 10,000) | If you exit after 1 year | ||
| Entry costs | This includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge. | Up to €500.00 | |
| Exit costs | We do not charge an exit fee for this product, but the person selling you the product may do so. | €0.00 | |
| Ongoing costs taken each year (Investment EUR 10,000) | |||
| Management fees and other administrative or operating costs | 1.52% of the value of your investment per year. This percentage is based on actual costs over the last year. | €143.93 | |
| Transaction costs | We do not charge a transaction fee for this product | €0.00 | |
| Incidental costs taken under specific conditions (Investment EUR 10,000) | |||
| Performance fees | 20.00% annual outperformance of the reference asset 100% ESTR CAPITALISE (OIS). The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years. The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset. | €0.00 | |
Codification
ISIN code
LU1103787930Bloomberg code
CPRRCIC LXReuters code
LP68277371Investment Objective
This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.
Documents
| Language | Documents | Type | Closing Date |
|---|---|---|---|
SV | PDF | 17/06/2026 | |
EN | PDF | 31/07/2025 | |
PDF | 01/10/2026 | ||
PDF | 31/01/2026 | ||
EN | PDF | 31/10/2026 | |
EN | PDF | 26/10/2016 |
Sustainability-related disclosures
| Language | Documents | Type | Closing Date |
|---|---|---|---|
SV | PDF | 01/01/2025 | |
EN | PDF | 03/08/2026 |